ROCKWELL MEDICAL, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ROCKWELL MEDICAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- ROCKWELL MEDICAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2019-09-30 was $0.00.
- ROCKWELL MEDICAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2019-06-30 was $0.00.
- ROCKWELL MEDICAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2019-03-31 was $147.90K.
- ROCKWELL MEDICAL, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $16.00K, a 77.78% increase from fiscal 2024.
- ROCKWELL MEDICAL, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $9.00K.
- ROCKWELL MEDICAL, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- ROCKWELL MEDICAL, INC. stock issued during period, value, stock options exercised for fiscal 2019 was $147.90K, a 118.96% increase from fiscal 2018.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $16.00K 10-K · filed 2026-03-26 | |
| 2024-12-31 | $9.00K 10-K · filed 2026-03-26 | |
| 2020-12-31 | $0.00 10-K · filed 2022-04-08 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $147.90K 10-K · filed 2021-03-31 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $217.43K derived: sum of 4 quarters · filed 2020-03-17 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $215.45K derived: sum of 4 quarters · filed 2020-03-17 |
| 2019-03-31 | $147.90K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $69.53K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $67.55K 10-K · filed 2020-03-17 |
| 2018-09-30 | -$1.98K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |